Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage-secreted brain-derived neurotrophic factor promotes tumor growth in triple-negative breast cancer by inducing axonogenesis.

Cell death and differentiation·2026
Same author

Fully human anti-FOLR1 T-cell engager demonstrates potent activity in CBFA2T3::GLIS2 acute megakaryoblastic leukemia.

Blood neoplasia·2026
Same author

Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant.

Journal of neuro-oncology·2026
Same author

Development of PROTACs for targeted degradation of oncogenic TRK fusions.

RSC chemical biology·2026
Same author

Beyond Histology: A Unified Transcriptomic Atlas Defines Lung Cancer Biologic States and Subtypes.

bioRxiv : the preprint server for biology·2026
Same author

A systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomas.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Apr 11, 2026

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.8K

Image-Guided Tumor Resection.

Julia Parrish-Novak1, Eric C Holland, James M Olson

  • 1From the *Research and Project Management, Blaze Bioscience, Inc; †Human Biology Division, Fred Hutchinson Cancer Research Center; and ‡Fred Hutchinson Cancer Research Center, Seattle, WA.

Cancer Journal (Sudbury, Mass.)
|June 8, 2015
PubMed
Summary
This summary is machine-generated.

Millions of cancer surgeries aim for cure, but outcomes depend on complete tumor removal. New fluorescent agents are being developed to help surgeons better distinguish cancer from healthy tissue, improving patient survival rates.

More Related Videos

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor
06:39

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Published on: May 23, 2025

565
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Related Experiment Videos

Last Updated: Apr 11, 2026

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.8K
Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor
06:39

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Published on: May 23, 2025

565
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Imaging

Background:

  • Cancer surgery is crucial for curative treatment, especially for chemo/radiation-resistant tumors.
  • Complete tumor resection significantly impacts patient survival rates in many solid cancers.
  • Investment in surgical outcome improvement lags behind other cancer treatment research.

Purpose of the Study:

  • To review recent advances in targeted fluorescent agents for cancer surgery.
  • To highlight the goal of improving cancer detection and removal during surgery.
  • To enhance surgical outcomes and patient survivorship.

Main Methods:

  • Review of recent scientific literature and technological developments.
  • Focus on targeted fluorescent agents designed for intraoperative guidance.
  • Analysis of strategies to differentiate cancerous from normal tissue.

Main Results:

  • Development of targeted fluorescent agents shows promise for intraoperative use.
  • These agents aim to improve the surgeon's ability to identify tumor margins.
  • Potential for increased rates of gross total resection and reduced residual disease.

Conclusions:

  • Targeted fluorescent agents represent a significant advancement in surgical oncology.
  • Improved visualization of cancer during surgery can lead to better patient outcomes.
  • Further investment and research in this area are warranted to optimize cancer treatment.